This case focuses on Nimbus Therapeutics, a biotechnology startup based in Cambridge, Massachusetts, as its leadership team tries to determine the company’s long-term strategy. The startup’s founders structured Nimbus as a limited liability company, which has given it more flexibility when it comes to funding and development partnerships. Does the operating structure still makes sense as Nimbus looks ahead to the future?
Keywords: Business Startups; Organizational Structure; Strategy; Biotechnology Industry;
Citation:
Barrett, Peter, Karim Lakhani, and Julia Kelley. "Nimbus Therapeutics." Harvard Business School Case 620-016, September 2019. View Details